Table 2.
Microbiology isolated by type of infection.
| n (%) | |
|---|---|
| Patients with co-infections/superinfections | 63 (66.3%) |
| Bacterial co-infections/superinfections | 33 (52.4%) |
| Bacterial and fungal co-infections/superinfections | 27 (42.9%) |
| Fungal co-infections/superinfections | 3 (4.8%) |
| Mixed co-infections/superinfections | 23 (36.5%) |
| Identified microbes | 162 |
| Bacteria | 130 (80.2%) |
| Gram-negative | 87 (66.9%) |
| Gram-positive | 43 (33.1%) |
| Fungi | 32 (19.8%) |
| Patients with pulmonary co-infection/superinfection | 52 (82.5%) |
| Identified respiratory microbes | 81 |
| Aspergillus spp. | 19 (23.5%) |
| Klebsiella pneumoniae | 16 (19.7%) |
| Pseudomonas aeruginosa | 8 (9.9%) |
| Acinetobacter baumannii | 8 (9.9%) |
| Staphylococcus aureus | 7 (8.6%) |
| Candida spp. | 6 (7.4%) |
| Escherichia coli | 4 (4.9%) |
| Enterococcus faecium | 3 (3.7%) |
| Stenotrophomonas maltophilia | 3 (3.7%) |
| Citrobacter spp. | 2 (2.5%) |
| Corynebacterium striatum | 2 (2.5%) |
| Streptococcus pneumoniae | 1 (1.2%) |
| Morganella morganii | 1 (1.2%) |
| Serratia mascescens | 1 (1.2%) |
| Patients with bloodstream co-infection/superinfection | 43 (68.2%) |
| Identified bloodstream microbes | 64 |
| Enterococcus faecium | 11 (17.2%) |
| Acinetobacter baumannii | 9 (14.1%) |
| Pseudomonas aeruginosa | 8 (12.5%) |
| Klebsiella Pneumoniae | 8 (12.5%) |
| Staphylococcus epidermidis | 8 (12.5%) |
| Staphylococcus aureus | 5 (7.8%) |
| Candida spp. | 4 (6.2%) |
| Escherichia coli | 4 (6.2%) |
| Enterococcus faecalis | 3 (4.7%) |
| Enterobacter spp. | 3 (4.7%) |
| Serratia marcescens | 1 (1.6%) |
| Patients with urinary tract co-infection/superinfection | 16 (25.4%) |
| Identified urinary microbes | 17 |
| Acinetobacter baumannii | 4 (23.5%) |
| Candida spp. | 3 (17.6%) |
| Escherichia coli | 3 (17.6%) |
| Enterococcus faecium | 3 (17.6%) |
| Klebsiella pneumoniae | 2 (11.8%) |
| Pseudomonas aeruginosa | 1 (5.9%) |
| Corynebacterium striatum | 1 (5.9%) |